Companies: 10,795·Total market cap: $144.5T
Helix BioMedix, Inc.

Helix BioMedix, Inc.

HXBMOTCHealthcare● Active
$1.79
+$0.00(+0.00%)
Market Cap$402227
P/E Ratio
52W High$6.45
52W Low$1

Helix BioMedix, Inc. (HXBM) Market Cap & Net Worth

Live market cap, enterprise value, and global rank — multi-year chart and annual table below.

hxbm · market cap & enterprise value · FMP · as of Jun 5, 2026

Core market cap & key metrics

As of Jun 5, 2026, Helix BioMedix, Inc. (HXBM) has a market cap — also referred to as its net worth or valuation — of $402,227, making it one of the top most valuable companies globally. Market Cap = $1.79 × shares outstanding.

Market Cap (Net Worth)$402,227hxbm market cap 2026
Enterprise ValuemktCap + debt − cash
1-Year Changevs one year ago
Global Rankinglargest company by mkt cap
All-Time High$0hxbm highest market cap ever
Stock Price$1.79OTC · Jun 5, 2026
How is Market Cap calculated?Market Cap = Stock Price × Shares Outstanding

About Market Cap, Net Worth & Valuation

Helix BioMedix, Inc. (HXBM) has a market cap — also referred to as its net worth or valuation — of $402,227 as of Jun 5, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.

Helix BioMedix, Inc. reached its all-time high market cap of $0 on —. Comparing the Helix BioMedix, Inc. market cap history illustrates one of the most extraordinary corporate growth stories.

Investors frequently compare Helix BioMedix, Inc. net worth vs peers and ask how Helix BioMedix, Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.

Data: FMP · year-end market cap · not investment advice

Frequently Asked Questions

HXBM market cap · 6 questions

Helix BioMedix, Inc.'s net worth — measured as market capitalization — is $402,227 as of Jun 5, 2026. It ranks #0 globally. Market Cap = $$1.79 (price) × shares outstanding.

HXBM net worth 2026market cap vs book valuelargest companies by market cap
Data: Financial Modeling Prep · Market cap updates daily · For informational purposes only, not investment advice.